Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Move Over, mRNA: What to Know About the Novavax COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
The Public Health Agency of Canada says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine,
Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year
TORONTO - The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing low demand.
17h
on MSN
Scientists develop mRNA vaccine that protects mice against intestinal C. difficile bacteria
A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...
CNET
6d
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
FierceBiotech
2d
Flexible mRNA vaccine protects mice from deadly C. diff infections, including recurring cases
The bacterium Clostridioides difficile is named “difficult” for a reason. Originally, it was hard to grow in the lab, and, ...
59m
on MSN
The Nobel Prize in medicine opens 6 days of award announcements
STOCKHOLM (AP) — The Nobel prizes award season begins Monday with the announcement by a panel at the Karolinska Institute in ...
Science News
3d
An mRNA vaccine protected mice against deadly intestinal C. difficile bacteria
An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.
2d
on MSN
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
5d
on MSN
Siloxane nanoparticles unlock precise organ targeting for mRNA therapy
Penn Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary ...
The Financial Express
13d
mRNA vaccines lead next-generation efforts to combat H5N1 amid global outbreaks: GlobalData
According to GlobalData, while the majority of the 22 vaccine candidates currently in development rely on traditional ...
3d
Should the federal government provide a non-mRNA vaccine for COVID-19 this respiratory virus season?
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...
6d
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, ...
1d
on MSN
Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Moderna
COVID-19
NASDAQ
CSL Limited
Nuvaxovid
Feedback